• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 68 of 100
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
FinanceAlere Is Suing to Force Abbott to Complete Their $5.8 Billion Merger
By ReutersAugust 26, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
FinanceWhat Mylan’s EpiPen Cost Scandal Says About the Drug Price Problem
By Jen WiecznerAugust 25, 2016
Coins2Day Most Powerful Women Summit 2015
HealthMylan Halves EpiPen Price After Being Savaged by Clinton
By Reuters and Coins2Day EditorsAugust 25, 2016
Mylan NV Chief Executive Officer Heather Bresch Interview
FinanceMylan CEO Blamed Obamacare for EpiPen Sticker Shock
By Jen WiecznerAugust 24, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
FinanceHere’s Why Mylan Has Something to Be Happy About Today
By Lucinda ShenAugust 24, 2016
Democratic Presidential Nominee Hillary Clinton Delivers Speech On The Economy
HealthPharma Bro Martin Shkreli Takes On Hillary Clinton Over Mylan’s EpiPen
By Sy MukherjeeAugust 24, 2016
A sign is seen at an AstraZeneca site in Macclesfield
HealthAstraZeneca Is Selling Its Antibiotics Business to Pfizer
By Reuters and Michelle TohAugust 24, 2016
Senator Amy Klobuchar, D-MN, listens to
HealthLawmakers Are Demanding Investigations Into Mylan’s Huge EpiPen Price Hike
By Sy MukherjeeAugust 23, 2016
Amid debate on drug prices, California leads way on cost controls
HealthHow Mylan Got Away With Its Enormous Price Hike for the EpiPen
By Sy MukherjeeAugust 22, 2016
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
FinanceValeant Is Said to Be Hiring This Zoetis Exec as Its New CFO
By Reuters and Michelle TohAugust 22, 2016
Pfizer In Merger Talks With Allergan PLC
FinancePfizer ‘In Advanced Talks’ to Acquire Medivation for About $14 Billion
By Reuters and Michelle TohAugust 21, 2016
Republican Presidential Candidates Hold Third Debate In Colorado
LeadershipWhy Donald Trump’s Anti-Trade Stance Worries Drug Companies
By Dylan Scott and STAT NewsAugust 20, 2016
HealthThis New Tuberculosis Drug Could Change the World
By Erika FryAugust 19, 2016
Female Sex Pill
HealthValeant’s Female Libido Pill Just Got Some Really Low Ratings
By Ed Silverman and STAT NewsAugust 18, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthT. Rowe Price Sues Valeant Over Alleged Fraud
By Sy MukherjeeAugust 18, 2016
1...
  • 66
  • 67
  • 68
  • 69
  • 70
...100
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.